Deficiency of ADAMTS-13 in thromboticand thrombocytopenic purpura

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 9, 2003, Pages 2038-2040

  Tsai, H M ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; METALLOPROTEINASE; VON WILLEBRAND FACTOR;

ENZYMOLOGY; HUMAN; METABOLISM; MOLECULAR WEIGHT; NOTE; RESEARCH; STANDARD; THROMBOCYTOPENIC PURPURA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PURPURA, THROMBOCYTOPENIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RESEARCH; VON WILLEBRAND FACTOR;

EID: 85047688875     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.t01-1-00377.x     Document Type: Note

References (11)

1. Remuzzi G. ADAMTS-13 deficiency is specific for thrombotic throm-bocytopenic purpura. J Thromb Haemost 2003; 1: 632-4.
2. Remuzzi G, Galbusera M, Noris M, Canciani MT, Daina E, Bresin E, Contaretti S, Caprioli J, Gamba S, Ruggenenti P, Perico N, Mannucci PM. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 2002; 100: 778-85.
3. Tsai HM. High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura. Am J Hematol 2000; 65: 251-5.
4. Tsai HM, Chandler WL, Sarode R, Hoffman R, Jelacic S, Habeeb RL, Watkins SL, Wong CS, Williams GD, Tarr PI. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 2001; 49: 653-9.
5. Tsai HM, Nagel RL, Sussman II. Subunit composition of plasma von Willebrand factor multimers: evidence for a non-proteolytic mechanism resulting in apparent increase in proteolytic fragments. Thromb Res 1991; 63: 179-88.
6. Tsai HM, Shulman K. Rituximab induces remission of cerebral ische mia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 2003; 70: 183-5.
7. Jubinsky P, Tsai HM. Thrombotic thrombocytopenic purpura in a newborn. J Perinatol 2003; 23: 85-7.
8. Savasan S, Taub JW, Buck S, Botterill M, Furlan M, Ravindranath Y. Congenital microangiopathic hemolytic anemia and thrombocytopenia with unusually large von Willebrand factor multimers and von Will-ebrand factor-cleaving protease. J Pediatr Hematol Oncol 2001; 23: 364-7.
9. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
10. Tsai HM. Severe deficiency of ADAMTS13 is specific for thrombotic thrombocytopenic purpura. J Thromb Haemost 2003; 1: 625-31.
11. Savasan S, Lee SK, Ginsburg D, Tsai HM. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Blood 2003; 101: 4449-51.